AI in Outpatient Practice for Diagnosing Aortic Stenosis and Diastolic Dysfunction
Part of paid clinical trials in Rochester, Minnesota.
- Sponsor
- Mayo Clinic
- Study ID
- NCT06580158
- Status
- Recruiting
Conditions
- Aortic Stenosis
- Diastolic Dysfunction
Eligibility Criteria
- Sex
- ALL
- Age
- 60 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- AI-ECG Dashboard — DEVICEPatients standard of care ECG's will be processed through the AI-ECG Dashboard
- Point of care ultrasound (POCUS) — DIAGNOSTIC_TESTPatients will undergo a ultrasound to confirm diagnosis of atrial stenosis or diastolic dysfunction.
Study Details
Two recently developed artificial intelligence-enabled electrocardiogram (AI-ECG) models have been developed to detect aortic stenosis (AS) and diastolic dysfunction (DD). AI-ECG for AS has a sensitivity of 78% and specificity of 74%, and AI-ECG for DD has a sensitivity of 83% and specificity of 80%. However, these models have never been prospectively applied to diagnose AS or DD, which may be useful for patients and providers from a diagnostic and prognostic perspective and especially in settings where access to higher- level medical care is limited. In this study, we aim to determine the clinical utility of these AI-ECG models by prospectively applying them to an outpatient cohort and then completing a focused point-of-care ultrasound to evaluate those who are AI-ECG positive for AS and DD.
Key Dates
- Start date
- Nov 8, 2024
- Status verified
- Jan 2026
- Primary completion
- Mar 31, 2027
- Completion
- Mar 31, 2027
Study Design
- Enrollment
- 2,000 participants (estimated)
Arms
- Arm: Patients who are completing an outpatient electrocardiogram (ECG) at the Mayo Clinic.
Primary Outcome Measure
Number of patients with positive AI-ECG [ Time Frame: Baseline ]
Central Contacts
- Brian Rudquist(507) 538-5146
- Jae Oh, M.D.
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic | Rochester | Minnesota | 55905 | Jae Oh, M.D. |
Find similar trials in Rochester, MN
Related Studies
- PARTNER 3 Trial - Aortic Valve-in-ValveRecruiting · Edwards Lifesciences · Phoenix, Arizona
- The HALT Biomarker StudyPHASE1 · Recruiting · Massachusetts General Hospital · Boston, Massachusetts
- Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve ReplacementRecruiting · University of British Columbia · Huntsville, Alabama
- A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve StenosisPHASE2 · Recruiting · Novartis Pharmaceuticals · Huntsville, Alabama